About
Alain Huriez has over 30 years of experience in Life Sciences and finance. He began as a General Practitioner before spending ten years in biotechnology drug development and regulatory strategy as vice president of Quintiles (IQVIA) Europe. From 2002 to 2012, he was a life sciences entrepreneur, associate partner at Truffle Capital, and CEO of Neovacs and TcLand-Effimune. Alain has founded five French biotechnology companies, including Theravectys and Samabriva. He was involved in personalized medicine initiatives as founder and chairman of EPEMED. In 2012, he joined Advent Life Sciences and founded AdBio Partners (formerly Advent France Biotechnology) in 2016. Alain was the first investor in Orphalan and chairman of the board between 2015 & 2022. His expertise spans clinical development, early-stage biotechnology projects, and mentoring managers.
Sign up to see Alain Huriez's full profile
Access investment thesis, focus areas, bio, and contact details for Alain Huriez and 22,000+ other VC professionals.
AdBio Partners
Paris, FR